Axsome Therapeutics Announces Publication of Pivotal GEMINI Phase 3 Trial of AXS-05 in Major Depressive Disorder in The Journal of Clinical Psychiatry
31 mai 2022 07h39 HE
|
Axsome Therapeutics, Inc.
NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
Deadline on December 2, 2013 in Lawsuit for Investors in J.C. Penney Company, Inc. (JCP) Shares Announced by Shareholders Foundation
23 oct. 2013 09h35 HE
|
Shareholders Foundation, Inc.
SAN DIEGO, Oct. 23, 2013 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a deadline to get actively involved is coming up on December 2, 2013 in the lawsuit filed on behalf of...